WallStSmart
AHCO

Adapthealth Corp

NASDAQ: AHCO · HEALTHCARE · MEDICAL DEVICES

$13.11
+0.23% today

Updated 2026-04-30

Market cap
$1.78B
P/E ratio
P/S ratio
0.55x
EPS (TTM)
$-0.52
Dividend yield
52W range
$8 – $13
Volume
1.5M

WallStSmart proprietary scores

40
out of 100
Grade: D
Sell
Investment rating
4.0
Growth
C
3.5
Quality
D
3.5
Profitability
D
6.7
Valuation
B
3/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$13.19
+0.61%
12-Month target
Intrinsic (DCF)
$63.70
Margin of safety
+83.45%
1 Strong Buy5 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $79.29M — positive
+ 83.45% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.99 — distress zone
- Thin margins at -2.18%
- Revenue declining -1.20% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$2.97B$3.20B$3.26B$3.24B$3.24B
Net income$69.32M$-678.89M$90.42M$-70.79M$-102.77M
EPS$-0.52
Free cash flow$-17.56M$143.20M$235.78M$219.38M$79.29M
Profit margin2.33%-21.21%2.77%-2.18%-2.18%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
AHCO$1.78B404.03.56.73.5+83.45%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Adapthealth Corp trades at $13.11. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.99, it sits in the distress. TTM revenue stands at $3.24B. with profit margins at -2.18%. Our DCF model estimates intrinsic value at $63.70.

Frequently asked questions

What is Adapthealth Corp's stock price?
Adapthealth Corp (AHCO) trades at $13.11.
Is Adapthealth Corp overvalued?
Smart Value Score 40/100 (Grade D, Sell). DCF value $63.70.
What is the price target of Adapthealth Corp (AHCO)?
The analyst target price is $13.19, representing +0.6% upside from the current price of $13.11.
What is the intrinsic value of Adapthealth Corp (AHCO)?
Based on our DCF model, intrinsic value is $63.70, a +83.5% margin of safety versus $13.11.
What is Adapthealth Corp's revenue?
TTM revenue is $3.24B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.99 — distress.

Company info

SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.55x
ROE-4.25%
Beta1.50
50D MA$11.10
200D MA$9.97
Shares out0.14B
Float0.09B
Short ratio
Avg volume1.5M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years